"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...

Most Oncologic Drugs Advisory Committee members took issue with the lack of dosing optimization and the lack of US patient ...

The Cambridge site of an international biotechnology company will cease manufacturing, leaving 150 people without a job.

While many believe the agents to be potential game changers, evidence is still lacking in psoriatic disease, and experts urge ...

Co-authors reported grants from Takeda Pharmaceuticals and UCB, consulting for GlaxoSmithKline, and personal fees from the ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

A global biopharmaceutical company headquartered in London announced the layoffs of 150 Massachusetts employees last week.

Sydnie Mason laughs with her lab partner at the SNC GlaxoSmithKline Summer Immersion Experience in Biotech, a biotechnology ...

Pakistan’s pharmaceutical sector stands as one of the steadily growing industries within the country’s economy.

The inhaler, with an older propellant, is already approved in Europe for the treatment of adults with chronic obstructive ...

Hepatitis B virus, a killer of more than one million people each year, is a notoriously wily virus, often lingering and ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...